Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Tofacitinib works better than methotrexate for severe alopecia in the short term.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Patients need better information about the risks of long-term steroid use.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

COVID-19 vaccination may trigger lupus in some people.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Stopping the beta-blocker nadolol led to quick hair regrowth and improved scalp condition.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Different people show different symptoms for genetic diseases because of how sensitive their bodies are to small changes in important factors.

Recognizing macro-TSH is crucial to avoid unnecessary treatments.

Red, swollen skin patches are a common allergic reaction to heparin injections, and testing with different heparin types can help find a suitable treatment.

Etanercept may cause lichen planopilaris, so doctors should be cautious.